MyChesCo on MSN19h
Revolution in Healthcare: FDA Greenlights First At-Home Test for Three Major STIs
The U.S. Food and Drug Administration (FDA) has granted Visby Medical marketing authorization for its Women’s Sexual Health Test, a groundbreaking diagnostic tool that allows at-home testing ...
Soleno Therapeutics Stock (SLNO) Surges on FDA Green Light for PWS Treatment
Soleno Therapeutics (SLNO) stock skyrocketed up over 42% this past week on news that it has achieved a significant milestone ...
DELPHINUS MEDICAL TECHNOLOGIES AND AUSTIN RADIOLOGICAL ASSOCIATION MARK MILESTONE IN ADVANCED SCREENING FOR WOMEN WITH DENSE BREASTS
Delphinus Medical Technologies and Austin Radiological Association (ARA) proudly announce the success of ARA’s SoftVue screening program, launched in December at their Cedar Park location. As the only ...
Targeting FDA user fees would leave agency gutted, experts say
Critics worry that the user fee program creates a conflict of interest between the FDA and pharmaceutical companies.
STAT3d
New tests for Alzheimer’s and cancer get FDA’s ‘breakthrough’ status
PathChat, a new AI model for pathology made by Modella AI, received breakthrough status in January. The device can digest ...
News-Medical.Net4d
Cabozantinib gains FDA approval for treating advanced neuroendocrine tumors
Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...
BioPharma Dive4d
FDA approves first-of-its-kind antibiotic from GSK
The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...
Le Lézard4d
Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors
Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...
FDA approves first new antibiotic for UTIs in nearly 30 years
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
CorMedix (CRMD) Q4 2024 Earnings Call Transcript
CorMedix (NASDAQ: CRMD) Q4 2024 Earnings Call Mar 25, 2025, 8:30 a.m. ET Good day, and welcome to the CorMedix Inc.
Tenon Medical, Inc.: Tenon Medical Announces FDA Clearance of Catamaran SI Joint Fusion System for New Indication to Augment Spinal Fusion
Achieves Significant Milestone with Expanded Use Indication, Opens Sizable New SI Market Opportunity ~ LOS GATOS, CA / ACCESS Newswire / March 24, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or ...